awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4
Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4
Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.
P2860
Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
054882e2b7492f739852cb57d026af0f33fc4274
P2860
Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer.